Fatma Rukiye Uysal

Fatma Rukiye Uysal

Auto-generated profile, based on publicly available information

Fatma Rukiye Uysal

Division of Nephrology, Department of Internal Medicine, Etlik City Hospital

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Hepatology Forum
Verified
Journal Article
Open access
PDF file
YPYavuz Emre Parlar
Yavuz Emre Parlar
HBhatice yasemin Balaban
hatice yasemin Balaban
UMUmit Yavuz Malkan
Umit Yavuz Malkan
EDErdogan Deniz
Erdogan Deniz
FUFatma Rukiye Uysal
Fatma Rukiye Uysal
D-penicillamine therapy is considered an effective and safe treatment for Wilson’s disease. Except for one experimental study, there has been no report in the literature about the development of disseminated intravascular coagulation (DIC) with the use of the drug. A 24-year-old female patient with Wilson’s disease, followed up with zinc and D-penicillamine treatment, was admitted to the emergency service because of oral mucosal bleeding and lethargy. Initial laboratory tests showed hemoglobin 7.1 g/dL (11.7-15.5), platelet 24×103 µL-1 (159-388), total bilirubin 18 mg/dL (0.3-1.2), direct bilirubin 9.8 mg/dL (0-0.2), INR >10 (0.8-1.2), aPTT 64.5 s (22.5-32), fibrinogen 23 mg/dL (180-350), and factor 8 26.4% (70-150). Melena, hematemesis, and hematochezia were not present, and no active bleeding focus was detected on endoscopic evaluation. Upon meeting the DIC criteria, the patient underwent plasma exchange four times for the treatment of acute-on-chronic liver failure. Haemocomplettan-P, cryoprecipitate replacements were made as a supportive treatment for DIC. As the clinical bleeding continued despite plasma exchanges and factor replacement treatment, D-penicillamine was switched to trientine (1250 mg/day). After this change, the mucosal bleeding stopped, and DIC parameters improved. We suggest that if hemorrhagic complications develop on D-penicillamine treatment, the possibility of DIC induced by D-penicillamine activating the fibrinolysis should also be considered.

14 October 2026 in Hitit Medical Journal
Verified
Journal Article
Open access
HŞHatice Şahin
Hatice Şahin
EYEmre Yasar
Emre Yasar
FEFatma Ebi̇nç
Fatma Ebi̇nç
GOGülay Ulusal Okyay
Gülay Ulusal Okyay
FUFatma Rukiye Uysal
Fatma Rukiye Uysal
MAMEHMET DENİZ AYLI
MEHMET DENİZ AYLI
Objective: Acute renal infarction (RI) is an uncommon condition with heterogeneous etiologies and potentially important renal sequelae. This study aimed to evaluate the clinical, laboratory, radiological, and treatment-related characteristics of patients with acute RI and to determine risk factors for acute kidney injury (AKI) at admission and chronic kidney disease (CKD) at 1 year.Materials and Methods: This retrospective observational study included patients with radiologically confirmed acute RI at two tertiary care centers in Ankara, Turkiye: Dışkapı Yıldırım Beyazıt Training and Research Hospital (1 January 2015 to 1 September 2022) and Ankara Etlik City Hospital (1 October 2022 to 28 February 2025). Multivariable logistic regression analysis was performed to identify predictors of AKI at admission. Firth penalized logistic regression was used to evaluate factors associated with CKD at 1 year because of the limited number of CKD events. Results: A total of 57 patients were enrolled; 56.1% were male and the mean age was 54.7 ± 13.8 years. AKI was present in 29 patients (50.9%), while CKD was observed in 13 patients (22.8%) at 1-year follow-up. In logistic regression analysis, older age was associated with AKI at admission (odds ratio [OR] = 1.058, 95% confidence interval [CI] 1.002-1.100; p=0.043), and AKI at admission remained associated with CKD at 1 year (penalized OR = 10.33, 95% CI 1.68–63.28; p=0.012).Conclusion: Patients with RI who had AKI at admission were at higher risk of developing CKD at 1 year. Older age was associated with AKI at admission. Post-discharge renal monitoring may be warranted, particularly for patients diagnosed with AKI.